Direct labeling of hMSC with SPIO: The long-term influence on toxicity, chondrogenic differentiation capacity, and intracellular distribution

Molecular Imaging and Biology

Volumn 13, Issue 3, 2011, Pages 443-451

  Yang, Chung Yi ^a,b   Hsiao, Jong Kai ^b   Tai, Ming Fong ^c   Chen, Shin Tai ^d   Cheng, Hui Ying ^b   Wang, Jaw Lin ^a   Liu, Hon Man ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^d LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chondrogenesis; Ferucarbotran; Mesenchymal stem cells

Indexed keywords

ALCIAN BLUE; FERUCARBOTRAN; REACTIVE OXYGEN METABOLITE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL LABELING; CELL SIZE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INCUBATION TIME; INHIBITION KINETICS; INTERNALIZATION; LYSOSOME; MESENCHYMAL STEM CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL DIFFERENTIATION; CHONDROGENESIS; DEXTRANS; EXTRACELLULAR MATRIX PROTEINS; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SPACE; MAGNETITE NANOPARTICLES; MESENCHYMAL STEM CELLS; MICROSCOPY, CONFOCAL; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; STAINING AND LABELING; TIME FACTORS;

EID: 79956202875     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-010-0360-7     Document Type: Article

References (46)

1. BM Abdallah M Kassem 2008 Human mesenchymal stem cells: from basic biology to clinical applications Gene Ther 15 109 116 17989700 10.1038/sj.gt.3303067 1:CAS:528:DC%2BD1cXhtlGqug%3D%3D
2. FP Barry JM Murphy 2004 Mesenchymal stem cells: clinical applications and biological characterization Int J Biochem Cell Biol 36 568 584 15010324 10.1016/j.biocel.2003.11.001 1:CAS:528:DC%2BD2cXhvFSmurg%3D (Pubitemid 38324589)
3. S Janssens C Dubois J Bogaert, et al. 2006 Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial Lancet 367 113 121 16413875 10.1016/S0140-6736(05)67861-0 (Pubitemid 43077127)
4. KC Wollert GP Meyer J Lotz, et al. 2004 Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial Lancet 364 141 148 15246726 10.1016/S0140-6736(04) 16626-9 (Pubitemid 38891685)
5. C Stamm B Westphal HD Kleine, et al. 2003 Autologous bone-marrow stem-cell transplantation for myocardial regeneration Lancet 361 45 46 12517467 10.1016/S0140-6736(03)12110-1 (Pubitemid 36050962)
6. MB Britten ND Abolmaali B Assmus, et al. 2003 Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging Circulation 108 2212 2218 14557356 10.1161/01.CIR.0000095788.78169.AF 1:STN:280:DC%2BD3srhvFSrtg%3D%3D (Pubitemid 37368893)
7. BE Strauer M Brehm T Zeus, et al. 2002 Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans Circulation 106 1913 1918 12370212 10.1161/01.CIR.0000034046.87607.1C (Pubitemid 35176294)
8. B Assmus V Schachinger C Teupe, et al. 2002 Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) Circulation 106 3009 3017 12473544 10.1161/01.CIR.0000043246.74879.CD (Pubitemid 35440281)
9. A Kaminski G Steinhoff 2008 Current status of intramyocardial bone marrow stem cell transplantation Semin Thorac Cardiovasc Surg 20 119 125 18707644 10.1053/j.semtcvs.2008.03.003
10. O Lindvall Z Kokaia 2006 Stem cells for the treatment of neurological disorders Nature 441 1094 1096 16810245 10.1038/nature04960 1:CAS:528: DC%2BD28Xmtlahs78%3D (Pubitemid 43990722)
11. O Lindvall Z Kokaia A Martinez-Serrano 2004 Stem cell therapy for human neurodegenerative disorders-how to make it work Nat Med 10 Suppl S42 S50 15272269 10.1038/nm1064 (Pubitemid 38901866)
12. CP Tsai Y Hung YH Chou, et al. 2008 High-contrast paramagnetic fluorescent mesoporous silica nanorods as a multifunctional cell-imaging probe Small 4 186 191 18205156 10.1002/smll.200700457 1:CAS:528:DC%2BD1cXisFSksro%3D (Pubitemid 351271148)
13. JW Bulte DL Kraitchman 2004 Iron oxide MR contrast agents for molecular and cellular imaging NMR Biomed 17 484 499 15526347 10.1002/nbm.924 1:CAS:528:DC%2BD2MXivFGq (Pubitemid 39549426)
14. AS Arbab LA Bashaw BR Miller, et al. 2003 Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging Radiology 229 838 846 14657318 10.1148/radiol.2293021215 (Pubitemid 37467591)
15. GT Yocum LB Wilson P Ashari EK Jordan JA Frank AS Arbab 2005 Effect of human stem cells labeled with ferumoxides-poly-L-lysine on hematologic and biochemical measurements in rats Radiology 235 547 552 15858093 10.1148/radiol.2352040383 (Pubitemid 40571095)
16. JA Frank BR Miller AS Arbab, et al. 2003 Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents Radiology 228 480 487 12819345 10.1148/radiol.2281020638 (Pubitemid 36910091)
17. JA Frank H Zywicke EK Jordan, et al. 2002 Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents Acad Radiol 9 Suppl 2 S484 S487 12188316 10.1016/S1076-6332(03)80271-4 (Pubitemid 34857762)
18. L Kostura DL Kraitchman AM Mackay MF Pittenger JW Bulte 2004 Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis NMR Biomed 17 513 517 15526348 10.1002/nbm.925 (Pubitemid 39549429)
19. P Reimer T Balzer 2003 Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications Eur Radiol 13 1266 1276 12764641 (Pubitemid 36790627)
20. V Mailander MR Lorenz V Holzapfel, et al. 2008 Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents Mol Imaging Biol 10 138 146 18297365 10.1007/s11307-007- 0130-3
21. JK Hsiao MF Tai HH Chu, et al. 2007 Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent: cellular behavior and capability of detection with clinical 1.5 T magnetic resonance at the single cell level Magn Reson Med 58 717 724 17899592 10.1002/mrm.21377 1:CAS:528:DC%2BD2sXht1SrtrzE (Pubitemid 47556876)
22. IJ de Vries WJ Lesterhuis JO Barentsz, et al. 2005 Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy Nat Biotechnol 23 1407 1413 16258544 10.1038/nbt1154 (Pubitemid 41679393)
23. TD Henning EJ Sutton A Kim, et al. 2009 The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells Contrast Media Mol Imaging 4 165 173 19670250 10.1002/cmmi.276 1:CAS:528:DC%2BD1MXhtVKhsrrM
24. AS Arbab LB Wilson P Ashari EK Jordan BK Lewis JA Frank 2005 A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging NMR Biomed 18 383 389 16013087 10.1002/nbm.970 1:CAS:528:DC%2BD2MXhtF2nsbbO (Pubitemid 41410358)
25. Hsiao JK, Chu HH, Wang YH, et al. (2008) Macrophage physiological function after superparamagnetic iron oxide labeling. NMR Biomed
26. T Okamoto T Aoyama T Nakayama, et al. 2002 Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells Biochem Biophys Res Commun 295 354 361 12150956 10.1016/S0006-291X(02)00661-7 1:CAS:528:DC%2BD38XltFersL8%3D (Pubitemid 34785842)
27. CW Lu Y Hung JK Hsiao, et al. 2007 Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling Nano Lett 7 149 154 17212455 10.1021/nl0624263 1:CAS:528:DC%2BD28Xht1OmsL7P (Pubitemid 46225844)
28. JK Hsiao CP Tsai TH Chung, et al. 2008 Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking Small 4 1445 1452 18680095 10.1002/smll.200701316 1:CAS:528:DC%2BD1cXhtF2gsLfL
29. E Pawelczyk AS Arbab S Pandit E Hu JA Frank 2006 Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging NMR Biomed 19 581 592 16673357 10.1002/nbm.1038 1:CAS:528:DC%2BD28XpsFejur8%3D
30. P Marchetti M Castedo SA Susin, et al. 1996 Mitochondrial permeability transition is a central coordinating event of apoptosis J Exp Med 184 1155 1160 9064332 10.1084/jem.184.3.1155 1:CAS:528:DyaK28XlsFartLY%3D (Pubitemid 26313572)
31. R Ogawa H Mizuno A Watanabe M Migita T Shimada H Hyakusoku 2004 Osteogenic and chondrogenic differentiation by adipose-derived stem cells harvested from GFP transgenic mice Biochem Biophys Res Commun 313 871 877 14706623 10.1016/j.bbrc.2003.12.017 1:CAS:528:DC%2BD2cXosFaq (Pubitemid 38050073)
32. Miot S, Gianni-Barrera R, Pelttari K, et al. (2009) In vitro and in vivo validation of human and goat chondrocyte labeling by GFP lentivirus transduction. Tissue Eng Part C Methods
33. L Rosenberg 1971 Chemical basis for the histological use of safranin O in the study of articular cartilage J Bone Joint Surg Am 53 69 82 4250366 1:CAS:528:DyaE3MXhtVOqt70%3D
34. F Barry RE Boynton B Liu JM Murphy 2001 Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components Exp Cell Res 268 189 200 11478845 10.1006/excr.2001.5278 1:CAS:528:DC%2BD3MXlsFChur4%3D (Pubitemid 32744650)
35. Y Wang DJ Blasioli HJ Kim HS Kim DL Kaplan 2006 Cartilage tissue engineering with silk scaffolds and human articular chondrocytes Biomaterials 27 4434 4442 16677707 10.1016/j.biomaterials.2006.03.050 1:CAS:528: DC%2BD28XkvVajtr0%3D
36. DM Huang Y Hung BS Ko, et al. 2005 Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking FASEB J 19 2014 2016 16230334 10.1096/fj.04-3104com 1:CAS:528:DC%2BD2MXhtlSmtb7I (Pubitemid 40617380)
37. AS Arbab GT Yocum LB Wilson, et al. 2004 Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability Mol Imaging 3 24 32 15142409 10.1162/153535004773861697 1:CAS:528:DC%2BD2cXkslGjsLg%3D
38. AS Arbab GT Yocum H Kalish, et al. 2004 Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI Blood 104 1217 1223 15100158 10.1182/blood-2004-02-0655 1:CAS:528:DC%2BD2cXmslKgtr8%3D (Pubitemid 39038047)
39. S Metz G Bonaterra M Rudelius M Settles EJ Rummeny HE Daldrup-Link 2004 Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro Eur Radiol 14 1851 1858 15249981 10.1007/s00330-004-2405-2 (Pubitemid 39386634)
40. RD Oude Engberink SM van der Pol EA Dopp HE de Vries EL Blezer 2007 Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function Radiology 243 467 474 17456871 10.1148/radiol. 2432060120 (Pubitemid 46649703)
41. MF Pittenger AM Mackay SC Beck, et al. 1999 Multilineage potential of adult human mesenchymal stem cells Science 284 143 147 10102814 10.1126/science.284.5411.143 1:CAS:528:DyaK1MXitlCnu7o%3D (Pubitemid 29282067)
42. ED Thomas HL Lochte Jr WC Lu JW Ferrebee 1957 Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy N Engl J Med 257 491 496 13464965 10.1056/NEJM195709122571102 1:STN:280:DyaG1c%2FgslKhtg%3D%3D
43. M Attal JL Harousseau AM Stoppa, et al. 1996 A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome N Engl J Med 335 91 97 8649495 10.1056/NEJM199607113350204 1:STN:280:DyaK283ms1emuw%3D%3D (Pubitemid 26240110)
44. S Wakitani T Goto SJ Pineda, et al. 1994 Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage J Bone Joint Surg Am 76 579 592 8150826 1:STN:280:DyaK2c3gtFaiuw%3D%3D (Pubitemid 24154130)
45. JW Bulte DL Kraitchman AM Mackay MF Pittenger 2004 Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides Blood 104 3410 3412 15525839 10.1182/blood-2004-06-2117 1:CAS:528:DC%2BD2cXhtVWhurjE author reply 3412-3413 (Pubitemid 39507168)
46. AS Arbab GT Yocum AM Rad, et al. 2005 Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells NMR Biomed 18 553 559 16229060 10.1002/nbm.991 1:CAS:528:DC%2BD28XosVSqtQ%3D%3D (Pubitemid 43013896)